综合模型在无创预测乳腺癌HER2状态方面优于单一影像组学模型
回顾性分析287例浸润性乳腺癌患者的术前乳腺MRI(脂肪抑制T2WI、轴位动态增强MRI、DWI序列),构建常规MRI特征模型、影像组学模型及两者联合的综合模型预测三分法HER2状态。训练集AUC分别为0.705、0.819、0.859,测试集为0.639、0.797、0.842;DeLong检验显示综合模型AUC显著优于影像组学模型(p<0.05),测试集NRI为25.0。
要点
- 综合模型(常规MRI+影像组学)预测三分法HER2状态的AUC在训练集0.859、测试集0.842。
- 影像组学模型AUC训练集0.819、测试集0.797,综合模型均高于单一影像组学模型。
- 测试集NRI 25.0支持综合模型较影像组学模型对HER2预测的改善。
核心结论
- 基于常规MRI与影像组学特征联合的综合模型在无创预测乳腺癌三分法HER2状态方面优于单一影像组学模型。
研究设计与样本
- 回顾性分析本院287例浸润性乳腺癌患者,按8:2随机分为训练集234例(HER2-zero 46例、HER2-low 107例、HER2-positive 81例)和测试集53例(HER2-zero 8例、HER2-low 27例、HER2-positive 18例)。
- 所有患者术前接受乳腺MRI,包括脂肪抑制T2加权成像、轴位动态增强MRI和扩散加权成像序列,并从中提取影像组学特征。
- 建立基于常规MRI特征、影像组学特征及两者联合的综合模型三种模型,采用受试者工作特征曲线分析评估预测能力,并用DeLong检验和净重分类改善(NRI)比较性能。
诊断标准与关键数值
- 常规MRI模型预测HER2状态的AUC在训练集为0.705、测试集为0.639。
- 影像组学模型预测HER2状态的AUC在训练集为0.819、测试集为0.797。
- 综合模型预测HER2状态的AUC在训练集为0.859、测试集为0.842。
- DeLong检验显示综合模型AUC显著高于影像组学模型(p<0.05)。
- 测试集NRI分析显示综合模型较影像组学模型对乳腺癌HER2预测更优(NRI 25.0)。
临床应用与阅片要点
- 作者结论认为,联合常规MRI与影像组学特征的综合模型在无创预测乳腺癌三分法HER2状态方面优于单一影像组学模型。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: This study aimed to develop predictive models based on conventional magnetic resonance imaging (cMRI) and radiomics features for predicting human epidermal growth factor receptor 2 (HER2) status of breast cancer (BC) and compare their performance.
MATERIALS AND METHODS: A total of 287 patients with invasive BC in our hospital were retrospectively analyzed. All patients underwent preoperative breast MRI consisting of fat-suppressed T2-weighted imaging, axial dynamic contrast-enhanced MRI, and diffusion-weighted imaging sequences. From these sequences, radiomics features were derived. Three distinct models were established utilizing cMRI features, radiomics features, and a comprehensive model that amalgamated both. The predictive capabilities of these models were assessed using the receiver operating characteristic curve analysis. The comparative performance was then determined through the DeLong test and net reclassification improvement (NRI).
RESULTS: In a randomized split, the 287 patients with BC were allotted to either training (234; 46 HER2-zero, 107 HER2-low, 81 HER2-positive) or test (53; 8 HER2-zero, 27 HER2-low, 18 HER2-positive) at an 8:2 ratio. The mean area under the curve (AUCs) for cMRI, radiomics, and comprehensive models predicting HER2 status were 0.705, 0.819, and 0.859 in training set and 0.639, 0.797, and 0.842 in test set, respectively. DeLong's test indicated that the combined model's AUC surpassed the radiomics model significantly (p < 0.05). NRI analysis verified superiority of the combined model over the radiomics for BC HER2 prediction (NRI 25.0) in the test set.
CONCLUSION: The comprehensive model based on the combination of cMRI and radiomics features outperformed the single radiomics model in noninvasively predicting the three-tiered HER2 status in patients with BC.
引用
- Liu W, Yang Y, Wang X, et al. A Comprehensive Model Outperformed the Single Radiomics Model in Noninvasively Predicting the HER2 Status in Patients with Breast Cancer. Acad Radiol. 2024. PMID: 39122586. doi:10.1016/j.acra.2024.07.048
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。